A detailed history of Wsfs Capital Management, LLC transactions in Amgen Inc stock. As of the latest transaction made, Wsfs Capital Management, LLC holds 12,729 shares of AMGN stock, worth $3.36 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares
12,729
Previous 12,703 0.2%
Holding current value
$3.36 Million
Previous $3.97 Million 3.33%
% of portfolio
0.22%
Previous 0.22%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

BUY
$309.38 - $337.38 $8,043 - $8,771
26 Added 0.2%
12,729 $4.1 Million
Q2 2024

Jul 30, 2024

SELL
$262.75 - $319.31 $14,976 - $18,200
-57 Reduced 0.45%
12,703 $3.97 Million
Q1 2024

May 01, 2024

SELL
$268.87 - $324.56 $242,520 - $292,753
-902 Reduced 6.6%
12,760 $3.63 Million
Q4 2023

Feb 02, 2024

SELL
$255.7 - $288.46 $1.4 Million - $1.58 Million
-5,491 Reduced 28.67%
13,662 $3.93 Million
Q3 2023

Nov 07, 2023

BUY
$218.65 - $271.46 $2.43 Million - $3.01 Million
11,104 Added 137.96%
19,153 $5.15 Million
Q2 2023

Aug 11, 2023

SELL
$214.27 - $253.37 $140,346 - $165,957
-655 Reduced 7.53%
8,049 $1.79 Million
Q1 2023

May 01, 2023

SELL
$225.79 - $275.2 $35,449 - $43,206
-157 Reduced 1.77%
8,704 $2.1 Million
Q4 2022

Feb 10, 2023

BUY
$229.03 - $291.01 $411,337 - $522,653
1,796 Added 25.42%
8,861 $2.33 Million
Q3 2022

Nov 03, 2022

SELL
$224.46 - $253.15 $11,447 - $12,910
-51 Reduced 0.72%
7,065 $1.59 Million
Q2 2022

Aug 10, 2022

SELL
$230.71 - $256.74 $25,839 - $28,754
-112 Reduced 1.55%
7,116 $1.73 Million
Q1 2022

May 13, 2022

BUY
$219.27 - $242.57 $1.58 Million - $1.75 Million
7,228 New
7,228 $1.75 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Wsfs Capital Management, LLC Portfolio

Follow Wsfs Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wsfs Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wsfs Capital Management, LLC with notifications on news.